2022
DOI: 10.3389/fcell.2022.915654
|View full text |Cite
|
Sign up to set email alerts
|

Single-Cell RNA Sequencing for Analyzing the Intestinal Tract in Healthy and Diseased Individuals

Abstract: The intestinal tract is composed of different cell lineages with distinct functions and gene expression profiles, providing uptake of nutrients and protection against insults to the gut lumen. Changes in or damage to the cellulosity or local environment of the intestinal tract can cause various diseases. Single-cell RNA sequencing (scRNA-seq) is a powerful tool for profiling and analyzing individual cell data, making it possible to resolve rare and intermediate cell states that are hardly observed at the bulk … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 90 publications
0
3
0
Order By: Relevance
“…Single-cell RNA sequencing (scRNA) has significantly expanded our understanding of multiple cellular microenvironments, including the gastrointestinal (GI) mucosal microenvironment that broadly consists of immune, stromal, and epithelial cell subtypes. However, high-fidelity capture of epithelial cells from human biopsy samples for transcriptional profiling remains challenging [1]. Prior scRNA studies of patient-derived colon biopsies have primarily utilized droplet-based scRNA (D-scRNA) platforms, but have well-described high rates of mitochondrial contaminant reads per cell [2, 3], which is a signature of dying or stressed cells that can result in potentially aberrant transcriptional profiles [4].…”
Section: Introductionmentioning
confidence: 99%
“…Single-cell RNA sequencing (scRNA) has significantly expanded our understanding of multiple cellular microenvironments, including the gastrointestinal (GI) mucosal microenvironment that broadly consists of immune, stromal, and epithelial cell subtypes. However, high-fidelity capture of epithelial cells from human biopsy samples for transcriptional profiling remains challenging [1]. Prior scRNA studies of patient-derived colon biopsies have primarily utilized droplet-based scRNA (D-scRNA) platforms, but have well-described high rates of mitochondrial contaminant reads per cell [2, 3], which is a signature of dying or stressed cells that can result in potentially aberrant transcriptional profiles [4].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, scRNA-Seq has been of great significance for in-depth analysis of the occurrence and development mechanisms of intestinal diseases, including identification of novel treatment targets and development of new treatment plans. 6 , 7 However, no previous study has used scRNA-Seq technology to reveal the functions and potential cell molecular mechanisms of different cellular subsets in intestinal tissue during AP-induced intestinal mucosal damage and drug treatment recovery process.…”
Section: Introductionmentioning
confidence: 99%
“…High-throughput single cell RNA sequencing (scRNA-Seq) is powerful for disclosing the complexity and diversity of cells and relationships among genes involved in tissues, and offers an opportunity to explore unbiased gene expression profiling of cells[ 20 ]. scRNA-Seq also provides insights into specific changes in cell lineages, trajectory inference, and the identification of biomarkers[ 21 , 22 ]. scRNA-seq has been used to study MSCs derived from adipose tissue, bone marrow, endometrium, placenta and dental pulp[ 23 - 27 ].…”
Section: Introductionmentioning
confidence: 99%